MRNA CAR T CELL TRAFFICKING FOLLOWING INTRA-VENTRICULAR ADMINISTRATION IN PRECLINICAL MODELS OF DIFFUSE MIDLINE GLIOMA

被引：0
|
作者：
Al-atrache, Zein [1 ]
Mcmanus, Olivia [1 ]
Harvey, Kyra [1 ]
Dickson, Conor [1 ]
Patterson, Luke [1 ]
Beaubien, Ezra [1 ]
Wilson, Cullen [1 ]
Hajeebu, Sreehita [1 ]
Keil, Samantha [2 ]
Braun, Molly [2 ]
Meechan, Michael [3 ]
Vitanza, Nicholas [4 ]
Iliff, Jeffrey [2 ]
Madsen, Peter [1 ]
Foster, Jessica [1 ]
机构：
[1] Childrens Hosp Philadelphia, Philadelphia, PA 19104 USA
[2] Univ Washington, Seattle, WA 98195 USA
[3] Seattle Childrens Res Inst, Seattle, WA USA
[4] Seattle Childrens Hosp, Seattle, WA USA
来源：
NEURO-ONCOLOGY | 2023年 / 25卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
IMMU-26
引用
收藏
页数：1
相关论文
共 13 条
  • [1] LOCOREGIONAL DELIVERY OF MRNA CAR T CELL THERAPY INTO THE CEREBROSPINAL FLUID IN PRECLINICAL MODELS OF DIFFUSE MIDLINE GLIOMA
    Harvey, Kyra
    Al-atrache, Zein
    McManus, Olivia
    Dickson, Conor
    Patterson, Luke
    Beaubien, Ezra
    Wilson, Cullen
    Hajeebu, Sreehita
    Keil, Samantha
    Braun, Molly
    Meechan, Michael
    Vitanza, Nicholas A.
    Iliff, Jeff
    Madsen, Peter
    Foster, Jessica
    NEURO-ONCOLOGY, 2024, 26
  • [2] CAR T cell therapies for diffuse midline glioma
    Thomas, Bryce C.
    Staudt, Dilana E.
    Douglas, Alicia M.
    Monje, Michelle
    Vitanza, Nicholas A.
    Dun, Matthew D.
    TRENDS IN CANCER, 2023, 9 (10): : 791 - 804
  • [3] SAFELY TARGETING GD2 IN THALAMIC DIFFUSE MIDLINE GLIOMA WITH MRNA CAR T CELLS
    Foster, Jessica
    Griffin, Crystal
    Stern, Allison
    Madsen, Peter
    Storm, Phillip
    Resnick, Adam
    NEURO-ONCOLOGY, 2022, 24 : 86 - 86
  • [4] TARGETING GD2 IN THALAMIC DIFFUSE MIDLINE GLIOMA WITH TRANSIENT MRNA CAR T CELLS
    Foster, Jessica
    Madsen, Peter
    Harvey, Kyra
    Patterson, Luke
    Griffin, Crystal
    Stern, Allison
    Storm, Phillip
    Resnick, Adam
    NEURO-ONCOLOGY, 2023, 25
  • [5] PRECLINICAL TESTING OF THE EFFICACY AND SAFETY OF CRISPR/CAS9 GENE EDITED CAR-T CELL THERAPY FOR DIFFUSE MIDLINE GLIOMA (DMG)
    Balakrishnan, Ilango
    Leach, Lillie
    Pierce, Angela
    Lakshmanachetty, Senthilnath
    Madhavan, Krishna
    Fosmire, Susan
    Chatwin, Hannah
    Green, Adam
    Fry, Terry
    Vibhakar, Rajeev
    Kohler, Eric. M.
    Venkataraman, Sujatha
    NEURO-ONCOLOGY, 2023, 25
  • [6] ONC201 AND ONC206 TARGET TUMOR CELL METABOLISM IN PEDIATRIC DIFFUSE MIDLINE GLIOMA PRECLINICAL MODELS
    Przystal, Justyna M.
    Cosentino, Chiara Cianciolo
    Yadavilli, Sridevi
    Zhang, Jie
    Laternser, Sandra
    Bonner, Erin R.
    Biery, Matt
    Vitanza, Nicholas A.
    Koschmann, Carl
    Cain, Jason
    Waszak, Sebastian M.
    Mueller, Sabine
    Nazarian, Javad
    NEURO-ONCOLOGY, 2021, 23 : 23 - 24
  • [7] ENHANCING GD2.CAR T CELL THERAPY FOR DIFFUSE MIDLINE GLIOMA WITH LSD1 AND HDAC INHIBITORS
    Murdaugh, Rebecca L.
    Shekar, Meghan
    Eberl, Brittany R.
    Tremblay, Jack R.
    Richard, Rosemary U.
    Nguyen, Linh
    Omer, Bilal
    Anastas, Jamie N.
    NEURO-ONCOLOGY, 2024, 26
  • [8] Immune signatures of GD2 CAR T cell activity in H3K27M+diffuse midline glioma patients
    Ramakrishna, Sneha
    Good, Zinaida
    Desai, Moksha
    Zamler, Daniel
    Mancusi, Rebecca
    Mahdi, Jasia
    Majzner, Robbie
    Schultz, Liora
    Richards, Rebecca
    Kamens, Jennifer
    Barsan, Valentin
    Campen, Cynthia
    Partap, Sonia
    Ehlinger, Zachary
    Reynolds, Warren
    Chen, Yiyun
    Hamilton, Mark P.
    Moon, Jennifer
    Baggott, Christina
    Kunicki, Michael
    Fujimoto, Michelle
    Li, Amy
    Jariwala, Sneha
    Mavroukakis, Sharon
    Egeler, Emily
    Jacobs, Ashley
    Erickson, Courtney
    Yamabe-Kwong, Karen
    Prabhu, Snehit
    Davis, Kara
    Feldman, Steve
    Sahaf, Bita
    Mackall, Crystal L.
    Monje, Michelle
    CANCER RESEARCH, 2023, 83 (07)
  • [9] Lenalidomide overcomes the resistance to third-generation CD19-CAR-T cell therapy in preclinical models of diffuse large B-cell lymphoma
    Zhen Jin
    Rufang Xiang
    Kai Qing
    Dan Li
    Zhao Liu
    Xiaoyang Li
    Hongming Zhu
    Yunxiang Zhang
    Lining Wang
    Kai Xue
    Han Liu
    Zizhen Xu
    Yingxiao Wang
    Junmin Li
    Cellular Oncology, 2023, 46 : 1143 - 1157
  • [10] Lenalidomide overcomes the resistance to third-generation CD19-CAR-T cell therapy in preclinical models of diffuse large B-cell lymphoma
    Jin, Zhen
    Xiang, Rufang
    Qing, Kai
    Li, Dan
    Liu, Zhao
    Li, Xiaoyang
    Zhu, Hongming
    Zhang, Yunxiang
    Wang, Lining
    Xue, Kai
    Liu, Han
    Xu, Zizhen
    Wang, Yingxiao
    Li, Junmin
    CELLULAR ONCOLOGY, 2023, 46 (04) : 1143 - 1157
12